SEC Filing Summary: Health & Nutrition Systems International, Inc.
Business Context and Reporting Period
This Form 8-K was filed on December 19, 2002, by Health & Nutrition Systems International, Inc. (a Florida corporation). The report addresses a material event occurring on the same date regarding the company's product portfolio.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory and operational disclosure rather than financial performance data.
Material Changes
The primary material change disclosed is the company's decision to discontinue all ephedrine-based products. This action was announced via a press release issued on December 19, 2002, and is incorporated by reference as Exhibit 99.1.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the product discontinuation. The filing does not contain forward-looking guidance, financial outlook, or a detailed discussion of risks beyond the implication of removing ephedrine products from the market. The decision appears to be a response to regulatory or market pressures surrounding ephedrine, though the filing text does not explicitly detail the underlying contingencies.
Key Facts for Investor Verification
- Verify the specific date and content of the press release (Exhibit 99.1) regarding the discontinuation of ephedrine products.
- Assess the revenue contribution of ephedrine-based products to the company's total sales prior to this decision.
- Confirm if there are any pending legal or regulatory actions related to the ephedrine products that necessitated this discontinuation.
- Review subsequent filings for the financial impact of this product line removal on future earnings.